Fierce 15: Two Partners Spinoffs Awarded Honors

Earlier this fall, Partners HealthCare spinoffs Editas Medicine and Spero received global recognition. Earlier this fall, Partners HealthCare spinoffs Editas Medicine and Spero received global recognition when they were named to the prestigious Fierce Biotech's Fierce 15, an annual compilation of leading biotech upstarts. Researchers around the globe are pursuing various strategies for correcting defective…

Read More

Fierce 15: Two Partners Spinoffs Awarded Honors

Earlier this fall, Partners HealthCare spinoffs Editas Medicine and Spero received global recognition. Earlier this fall, Partners HealthCare spinoffs Editas Medicine and Spero received global recognition when they were named to the prestigious Fierce Biotech's Fierce 15, an annual compilation of leading biotech upstarts. Researchers around the globe are pursuing various strategies for correcting defective…

Read More

CoStim's Novel Biologics Target Immune Checkpoint Inhibitors

Partners HealthCare spin-off, CoStim Pharmaceuticals, positioned to be a leader in the immune checkpoint regulation market. With excitement growing around immune checkpoint regulation as a major advance in treating cancer, the emergence of Partners HealthCare spin-off CoStim Pharmaceuticals could not be better timed. Industry experts expect the immune checkpoint therapy market will continue to grow…

Read More